BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 37248504)

  • 1. Comparison of different dose accumulation strategies to estimate organ doses after stereotactic magnetic resonance-guided adaptive radiotherapy.
    Regnery S; Leiner L; Buchele C; Hoegen P; Sandrini E; Held T; Deng M; Eichkorn T; Rippke C; Renkamp CK; König L; Lang K; Adeberg S; Debus J; Klüter S; Hörner-Rieber J
    Radiat Oncol; 2023 May; 18(1):92. PubMed ID: 37248504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of On-Table Plan Adaptation in MR-Guided Ablative Radiation Therapy for Central Lung Tumors.
    Finazzi T; Palacios MA; Spoelstra FOB; Haasbeek CJA; Bruynzeel AME; Slotman BJ; Lagerwaard FJ; Senan S
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):933-941. PubMed ID: 30928360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of MR-guided radiotherapy accumulated doses for central lung tumors with non-adaptive and online adaptive proton therapy.
    Rabe M; Palacios MA; van Sörnsen de Koste JR; Eze C; Hillbrand M; Belka C; Landry G; Senan S; Kurz C
    Med Phys; 2023 May; 50(5):2625-2636. PubMed ID: 36810708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of treatment planning workflow and tumor coverage during daily adaptive magnetic resonance image guided radiation therapy (MR-IGRT) of pancreatic cancer.
    Olberg S; Green O; Cai B; Yang D; Rodriguez V; Zhang H; Kim JS; Parikh PJ; Mutic S; Park JC
    Radiat Oncol; 2018 Mar; 13(1):51. PubMed ID: 29573744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simulated daily plan adaptation for magnetic resonance-guided liver stereotactic body radiotherapy.
    Taylor E; Lukovic J; Velec M; Shessel A; Stanescu T; Dawson L; Létourneau D; Lindsay P
    Acta Oncol; 2021 Feb; 60(2):260-266. PubMed ID: 33170058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?
    Murrell DH; Laba JM; Erickson A; Millman B; Palma DA; Louie AV
    Radiat Oncol; 2018 Apr; 13(1):57. PubMed ID: 29606150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel four-dimensional radiotherapy planning strategy from a tumor-tracking beam's eye view.
    Li G; Cohen P; Xie H; Low D; Li D; Rimner A
    Phys Med Biol; 2012 Nov; 57(22):7579-98. PubMed ID: 23103415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of online adaptive MR-guided stereotactic body radiotherapy of liver cancers.
    Padgett KR; Simpson G; Asher D; Portelance L; Bossart E; Dogan N
    Phys Med; 2020 Sep; 77():54-63. PubMed ID: 32781388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers.
    Liu Q; Liang J; Zhou D; Krauss DJ; Chen PY; Yan D
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):985-997. PubMed ID: 29976511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit of replanning in MR-guided online adaptive radiation therapy in the treatment of liver metastasis.
    Mayinger M; Ludwig R; Christ SM; Dal Bello R; Ryu A; Weitkamp N; Pavic M; Garcia Schüler H; Wilke L; Guckenberger M; Unkelbach J; Tanadini-Lang S; Andratschke N
    Radiat Oncol; 2021 May; 16(1):84. PubMed ID: 33947429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledge-based planning using both the predicted DVH of organ-at risk and planning target volume.
    Jiao SX; Wang ML; Chen LX; Liu XW
    Med Eng Phys; 2022 Dec; 110():103803. PubMed ID: 35461772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of dose-volume histogram prediction for organ-at risk and planning target volume based on machine learning.
    Jiao SX; Wang ML; Chen LX; Liu XW
    Sci Rep; 2021 Feb; 11(1):3117. PubMed ID: 33542427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient's specific integration of OAR doses (D2 cc) from EBRT and 3D image-guided brachytherapy for cervical cancer.
    Gelover E; Katherine C; Mart C; Sun W; Kim Y
    J Appl Clin Med Phys; 2018 Mar; 19(2):83-92. PubMed ID: 29349933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of the delivered dose based on cone-beam CT and deformable image registration for non-small cell lung cancer treated with hypofractionated radiotherapy.
    Wang B; Wang DQ; Lin MS; Lu SP; Zhang J; Chen L; Li QW; Cheng ZK; Liu FJ; Guo JY; Liu H; Qiu B
    BMC Cancer; 2020 Nov; 20(1):1112. PubMed ID: 33198676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer.
    Da Silva Mendes V; Nierer L; Li M; Corradini S; Reiner M; Kamp F; Niyazi M; Kurz C; Landry G; Belka C
    Radiat Oncol; 2021 Jul; 16(1):133. PubMed ID: 34289868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric comparison of two treatment planning systems for spine SBRT.
    Lee YK; Munawar I; Mashouf S; Sahgal A; Ruschin M
    Med Dosim; 2020 Spring; 45(1):77-84. PubMed ID: 31376988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptive MR-Guided Stereotactic Radiotherapy is Beneficial for Ablative Treatment of Lung Tumors in High-Risk Locations.
    Regnery S; Buchele C; Weykamp F; Pohl M; Hoegen P; Eichkorn T; Held T; Ristau J; Rippke C; König L; Thomas M; Winter H; Adeberg S; Debus J; Klüter S; Hörner-Rieber J
    Front Oncol; 2021; 11():757031. PubMed ID: 35087746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technical note: Optimization functions for re-irradiation treatment planning.
    Ödén J; Eriksson K; Svensson S; Lilley J; Thompson C; Pagett C; Appelt A; Murray L; Bokrantz R
    Med Phys; 2024 Jan; 51(1):476-484. PubMed ID: 37921262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric impact of organ at risk daily variation during prostate stereotactic ablative radiotherapy.
    Devlin L; Dodds D; Sadozye A; McLoone P; MacLeod N; Lamb C; Currie S; Thomson S; Duffton A
    Br J Radiol; 2020 Apr; 93(1108):20190789. PubMed ID: 31971829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.